Immunome

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

AENT

HNRG

IMNM

NVDA


According to several indicators—including a robust labor market and tamed inflation figures—the U.S. economy heads into 2025 with strong tailwinds. Many of the securities that have been primary beneficiaries

3 Small-Cap Stocks With Big Growth Potential

Immunome Inc

Press Releases

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Health Care

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

Immunome Provides Pipeline Update in Advance of Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

Immunome Announces Proposed Public Offering of Common Stock

Immunome Announces Pricing of Upsized Public Offering of Common Stock

Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Aro Biotherapeutics Announces Leadership Transition and Appoints Purnanand Sarma, Ph.D., as Chief Executive Officer

Immunome to Present at Upcoming March Conferences

ArriVent BioPharma

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

Bicara Therapeutics

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Cogent Biosciences

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Geron

Gyre Therapeutics

Kura Oncology

LENZ Therapeutics

Myriad Genetics

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics

Opthea Limited - American Depositary Shares

Opthea

Organogenesis Hldgs

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

Prothena Corporation plc - Ordinary Shares

Prothena Corp

Rocket Pharmaceuticals, Inc. - Common Stock

Comments

Immunome

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga